Stay updated on NIB in TNBC Clinical Trial

Sign up to get notified when there's something new on the NIB in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NIB in TNBC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:21:26.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8, indicating a shift in the number of patients planned to be enrolled in a phase II study exploring the combination of pembrolizumab with nab-paclitaxel and pembrolizumab with epirubicin and cyclophosphamide for women with early triple negative breast cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:06.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of what eligibility criteria entail in the context of clinical research.
    Difference
    34%
    Check dated 2024-05-22T21:12:26.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:37:22.000Z thumbnail image

Stay in the know with updates to NIB in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NIB in TNBC Clinical Trial page.